Regeneron NewsLatest News On Regeneron Pro Research: Wall Street dives into Regeneron's robust prospects3/31/2024 4:36 AM High School Students Making Strides in Cancer Research3/21/2024 6:18 AM High-school students are making strides in cancer research: ‘Gives me hope'3/20/2024 4:26 AM Regeneron beats quarterly profit estimates on eczema treatment strength11/2/2023 5:23 AM Regeneron Pharma’s adjusted earnings beat estimates11/2/2023 5:01 AM Regeneron Pharma adjusted earnings beat estimates11/2/2023 4:52 AM Regeneron CFO Landry to retire, top accountant Fenimore to become CFO9/8/2023 6:07 PM HHS Announces Details of Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies9/8/2023 5:44 PM US govt awards $1.4 bln for development of new COVID therapies, vaccines8/22/2023 5:01 PM Regeneron gets federal funding for next-generation COVID treatment8/22/2023 3:45 PM This biotech name is one of Jim Cramer's favorite stocks and he thinks it can go even higher8/21/2023 12:01 PM Regeneron Stock-Price Targets Rise as FDA Approves Higher Dose of Eye Drug8/21/2023 10:25 AM Regeneron shares climb after FDA approval of macular degeneration treatment8/21/2023 9:01 AM US FDA approves Regeneron's 8-mg dose of eye disease drug Eylea By Reuters8/18/2023 8:41 PM Regeneron gets FDA green light on first treatment for life-threatening immune disease8/18/2023 3:19 PM Regeneron to Acquire Decibel Therapeutics for $4 a Share8/9/2023 8:56 AM Regeneron expects FDA decision on high-dose eye drug this year, shares jump8/3/2023 11:25 AM Regeneron’s stock rallies after profit, revenue rise above expectations, amid a jump in collaboration revenue8/3/2023 9:14 AM US FDA declines to approve Regeneron's higher-dose Eylea, shares tumble6/27/2023 8:05 PM Regeneron shares fall after FDA rejects high-dose eye disease treatment6/27/2023 5:57 PM